SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER is a Topical Emulsion in the Human Otc Drug category. It is labeled and distributed by Shiseido Americas Corporation. The primary component is Titanium Dioxide; Octinoxate; Ensulizole.
| Product ID | 58411-657_5372d970-e30f-48ff-b10f-2b2f74dfccc9 |
| NDC | 58411-657 |
| Product Type | Human Otc Drug |
| Proprietary Name | SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER |
| Generic Name | Titanium Dioxide, Octinoxate, And Ensulizole |
| Dosage Form | Emulsion |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2021-05-01 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / |
| Application Number | part352 |
| Labeler Name | SHISEIDO AMERICAS CORPORATION |
| Substance Name | TITANIUM DIOXIDE; OCTINOXATE; ENSULIZOLE |
| Active Ingredient Strength | 2 g/40mL; g/40mL; g/40mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |